Cerebral hyperperfusion syndrome after stenting for revascularization of intracranial internal carotid artery

Takayuki Funatsu1, Hirotoshi Imamura1, Shoichi Tani1

  • 1Department of Neurosurgery, Kobe City Medical Center General Hospital, 2-1-1, Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan.

Insights

Cerebral hyperperfusion syndrome (CHS) can occur after revascularization procedures. This case highlights CHS risk even after short-term hypoperfusion in intracranial arterial dissection.

Area of Science:

  • Neurology
  • Neurosurgery
  • Vascular Surgery

Background:

  • Cerebral hyperperfusion syndrome (CHS) is a known complication following cerebral revascularization.
  • Impaired cerebral autoregulation due to prolonged hypoperfusion is the primary suspected cause of CHS.
  • Intracranial arterial dissection (IAD) associated with internal carotid artery stenosis presents a unique clinical challenge.

Observation:

  • A 40-year-old male with symptomatic IAD and severe cerebral hypoperfusion underwent intracranial stenting.
  • The patient developed CHS with an intracerebral hemorrhage post-operatively.
  • This event occurred 11 days after the initial onset of symptoms.

Findings:

  • Intracranial stenting in the context of IAD-related stenosis carries a risk of CHS.
  • Even brief periods of cerebral hypoperfusion may predispose patients to developing CHS.
  • The pathophysiology may involve rapid changes in cerebral blood flow and autoregulation.

Implications:

  • This case expands the understanding of CHS risk factors beyond long-standing hypoperfusion.
  • It underscores the importance of careful patient selection and monitoring after intracranial stenting for IAD.
  • Further research is warranted to elucidate the mechanisms of CHS in acute hypoperfusion scenarios.